A Phase I Study of XJ103 in Chinese Healthy Subjects

Clinical trial NCT06026748 · UNKNOWN

Trial details

NCT number: NCT06026748
Sponsor: Starmab biologics（Shanghai）Co,.ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2023-09-12
Primary completion: 2024-12-24
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.